Compound library
Understand what people are taking.
Browse medicines, supplements, herbs, and health foods. Each profile brings community reports and linked research into one clear view.
Browse medicines, supplements, herbs, and health foods. Each profile brings community reports and linked research into one clear view.
Polyphenol from grape skins and Japanese knotweed, famous for extending lifespan in yeast and mice. It has been tested in many human trials without convincing clinical benefit. Umbrella reviews rate its effects on blood sugar, cholesterol and blood pressure as trivial or very low certainty, and a meta-analysis of human brain and mood trials found the animal results are not replicated in people.
3 of 9 results reported a benefit, from 2 published studies.
2 studies, including a review of trials
These are the figures the studies reported, not a prediction for any one person. Where several studies measured the same thing in the same unit, we show a simple average and say so. Every individual result is listed below.
See every resultCardiovascular health — blood pressure, cholesterol, heart function, and circulation.
Also known as: trans-Resveratrol
Every published result for this pair, extracted and audited.
These charts group published studies by what they reported and how they were run — green marks studies that reported a benefit for this pairing. Tiers run from pooled analyses of many trials (strongest) to one-off observational reports.
Direction of reported outcomes for Resveratrol in heart health.
Study designs behind these findings.
Hand-selected PubMed studies, linked to the originals.
Ordered by strength of evidence, then result direction.
01Taurine supplementation as a therapeutic strategy for cellular senescence and chronic inflammation in long COVID: a systematic review and meta-analysisWang K, et al. · BMC infectious diseases · 2026PMID 41803812 ↗02Energy Drinks as the Legal Cocaine? A Comparative Review of Cardiac Physiopathological and Histopathological PatternsGhamlouch A, et al. · Cardiovascular toxicology · 2025PMID 41266869 ↗03Evaluating the efficacy of ubiquinol in heart failure patients: a systematic review and meta-analysisQazi SU, et al. · Future cardiology · 2024PMID 39049769 ↗04Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysisTzang CC, et al. · Nutrition journal · 2024PMID 39148075 ↗Be the first to share what you noticed with Resveratrol for heart health. Why counts start empty.
Every measured outcome, one row per finding - numbers exactly as reported.
| Study | Design | n | Duration | Outcome measured | Reported result | Direction |
|---|---|---|---|---|---|---|
| PMID 35833325 2022 | Meta-analysis | - | - | fibrinogen | reported qualitatively | No benefit |
| PMID 35833325 2022 | Meta-analysis | - | - | flow-mediated dilation (FMD) | 1.43% (95% CI: 0.98 to 1.88, p < .001) | Benefit |
| PMID 35833325 2022 | Meta-analysis | - | - | intracellular adhesion molecule-1 (ICAM-1) | -7.09 ng/ml (95% CI: -7.45 to -6.73, p < .001) | Benefit |
| PMID 35833325 2022 | Meta-analysis | - | - | plasminogen activator inhibitor-1 (PAI-1) | reported qualitatively | No benefit |
| PMID 35833325 2022 | Meta-analysis | - | - | vascular adhesion molecule-1 (VCAM-1) | reported qualitatively | No benefit |
| PMID 29359958 2019 | Meta-analysis | - | - | Diastolic blood pressure | reported qualitatively (95% CI:(-2.2, 1.3) mmHg; p=0.613) | No benefit |
| PMID 29359958 2019 | Meta-analysis | - | - | Mean arterial pressure | reported qualitatively (95% CI:(-2.8, 0.1) mmHg; p=0.070) | No benefit |
| PMID 29359958 2019 | Meta-analysis | - | - | Systolic blood pressure | reported qualitatively (95% CI:(-5.5, 0.6) mmHg; p=0.116) | No benefit |
| PMID 29359958 2019 | Meta-analysis | - | - | Systolic blood pressure, high-dose (300 mg/day or more) and diabetic subgroups | reported qualitatively | Benefit |